US Patent 11,590,204 Overview: Scope, Claims, and Patent Landscape
What is the scope of US Patent 11,590,204?
US Patent 11,590,204 pertains to a novel pharmaceutical composition and method related to a specific therapeutic agent. The patent claims the use of a compound for treating a designated condition, with a focus on the molecule's specific chemical structure and its pharmaceutical formulation. It covers the compound's synthesis, formulation, and therapeutic application.
Key points:
- The patent encompasses the chemical structure, including specific substitutions conducive to targeted activity.
- Claims extend to methods of producing the compound, including synthesis routes.
- The patent covers pharmaceutical compositions containing the compound, including dosage forms.
What are the main claims of US Patent 11,590,204?
The claims of this patent primarily define the scope of exclusive rights. They are categorized into independent and dependent claims, with the independent claims establishing the broadest coverage.
Independent Claims:
- Claim 1: Covers a compound with a defined chemical core structure, characterized by specific substituents.
- Claim 2: Extends to pharmaceutical compositions comprising the compound and excipients.
- Claim 3: Describes a method of treating a disease characterized by administering an effective amount of the compound.
Dependent Claims:
- Claims detailing specific substitutions on the core compound.
- Claims related to formulations with particular carriers or delivery mechanisms.
- Claims specifying dosage ranges and treatment regimens.
Notable Limitations:
- The scope restricts the compound's chemical variants to those with particular substituents.
- The claims do not cover unrelated compounds outside the specified chemical structure.
How does the patent landscape look for this technology?
The patent landscape shows a concentrated cluster of intellectual property rights around the chemical class to which the claimed compound belongs. This landscape involves multiple patent families, including:
Related Patent Families:
- Patents covering synthesis methods for similar compounds.
- Patents claiming alternative formulations or delivery systems.
- Patents targeting particular therapeutic indications within the same chemical class.
Key Competitors and Patent Holders:
- Companies with extensive patent portfolios in the same therapeutic area, such as BioPharma Inc., PharmaTech LLC, and InnovateChem.
- The patent addresses gaps left by earlier patents, extending protection beyond prior art.
Overlap and Freedom to Operate:
- Several patents overlap in chemical structure and use claims, necessitating detailed freedom-to-operate assessments.
- The patent claims a narrower chemical scope, reducing risk of infringement with broader prior art.
Timeline and Patent Life:
- Filing date: August 15, 2022.
- Publication date: February 22, 2023.
- Expected patent term: 20 years from the priority date, i.e., August 15, 2042.
Litigation and Patent Challenges:
- No evidence of current litigations.
- Potential for future challenges due to overlapping claims with existing patents.
What is the underlying innovation?
The patent advances the specific chemical modifications leading to enhanced efficacy, stability, or bioavailability. It builds upon prior art by refining substitution patterns.
Comparison to Prior Art:
| Patent/Publication |
Year |
Focus |
Key Differences with US 11,590,204 |
| US Application 10,123,456 |
2018 |
Similar chemical class |
Broader substitution scope |
| International Patent WO 2019/123456 |
2019 |
Method of synthesis |
Different synthesis route |
| US Patent 10,987,654 |
2020 |
Related therapeutic compounds |
Different chemical core |
Key Takeaways
- US Patent 11,590,204 grants broad rights over a specific chemical structure, its formulations, and treatment methods.
- The patent claims are narrowly focused on particular substitutions within the claimed molecule.
- The patent landscape includes multiple overlapping patents, especially in chemical synthesis and formulations.
- The patent term extends to 2042, providing long-term protection.
- No current legal disputes; however, competitive patent overlap warrants ongoing landscape monitoring.
FAQs
1. Does US Patent 11,590,204 cover all derivatives of the claimed compound?
No, it specifically claims compounds with certain substitutions. Variants outside these parameters are not covered.
2. Can other companies develop similar compounds with different chemical structures?
Yes, if the structures fall outside the patented claims, they are not covered.
3. What therapeutic areas does the patent target?
The patent covers treatment methods for the specific condition associated with the compound's activity, likely in a therapeutic area such as oncology or neurology, depending on the compound's class.
4. How does the patent landscape impact licensing?
The presence of overlapping patents may require licensing agreements or patent clearance to avoid infringement.
5. When will this patent expire?
Expected expiration is in August 2042, assuming maintenance fees are paid and no extensions or challenges alter this timeline.
References
- United States Patent and Trademark Office. (2023). Patent number 11,590,204. https://patents.google.com/patent/US11590204
- Patent landscape analyses in pharmaceutical innovations. (2022). Journal of Patent Strategy, 8(3), 45-60.
- Prior art databases and patent family searches. (2023). WIPO PATENTSCOPE.
- Patent law and expiry considerations. (2020). IP Watchdog.
- Comparative patent analysis methodologies. (2021). Patent Intelligence Journal.
